These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6169376)

  • 1. The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women.
    Banki CM; Molnar G
    Biol Psychiatry; 1981 Aug; 16(8):753-62. PubMed ID: 6169376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 1. Background variables.
    Banki CM; Vojnik M; Molnar G
    J Affect Disord; 1981 Jun; 3(2):81-9. PubMed ID: 6166644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression.
    Banki CM; Molnar G; Fekete I
    Arch Psychiatr Nervenkr (1970); 1981; 229(4):345-53. PubMed ID: 6164353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
    Abrams R; Essman WB; Taylor MA; Fink M
    Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid biochemical examinations: do they reflect clinical or biological differences?
    Banki CM; Arató M; Papp Z
    Biol Psychiatry; 1983 Sep; 18(9):1033-44. PubMed ID: 6196059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid amine metabolites in delirium tremens.
    Banki CM; Molnar G
    Psychiatr Clin (Basel); 1981; 14(3):167-77. PubMed ID: 6173895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and somatosensory evoked potentials: I. Correlations between SEP and monoamine and purine metabolites in CSF.
    Agren H; Osterberg B; Niklasson F; Franzén O
    Biol Psychiatry; 1983 Jun; 18(6):635-49. PubMed ID: 6191784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms.
    Banki CM; Molnar G; Vojnik M
    J Affect Disord; 1981 Jun; 3(2):91-9. PubMed ID: 6166645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence.
    Banki CM
    J Neural Transm; 1981; 50(2-4):89-101. PubMed ID: 6165805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measuring monoamine metabolites and tryptophan levels in the cerebrospinal fluid of alcohol-dependent patients].
    Bánki MC
    Orv Hetil; 1981 Oct; 122(40):2463-9. PubMed ID: 6172767
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T; Eriksson M; Sjöberg S; Nordin C
    J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow.
    Young SN; Lal S; Martin JB; Ford RM; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(6):439-44. PubMed ID: 4781523
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebrospinal HVA and 5-HIAA in patients with endogenous depression in the course of treatment].
    Loeb DC; Roccatagliata G; Albano C; Abbruzzese G
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):27-32. PubMed ID: 6158092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF neurochemistry of women with anorexia nervosa and normal women.
    Gerner RH; Cohen DJ; Fairbanks L; Anderson GM; Young JG; Scheinin M; Linnoila M; Shaywitz BA; Hare TA
    Am J Psychiatry; 1984 Nov; 141(11):1441-4. PubMed ID: 6208797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF).
    Sourkes TL; Young SN; Garelis E; Lal S
    Acta Vitaminol Enzymol; 1975; 29(1-6):97-9. PubMed ID: 1244132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?
    Niklasson F; Agren H; Hällgren R
    J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):255-60. PubMed ID: 6188805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of peripheral decarboxylase inhibition on HVA and 5HIAA in cerebrospinal fluid of depressed patients.
    Gaillard JM; Constantinidis J; Tissot R
    Neuropsychobiology; 1975; 1(1):26-31. PubMed ID: 1223666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.